Analysis of KIR genes in HLA-identical sibling hematopoietic stem cell transplantation in Thai patients with Leukemia

Journal of the Medical Association of Thailand

Volumn 95, Issue 10, 2012, Pages 1261-1265

  Wongwuttisaroj, Natta ^a   Vejbaesya, Sasijit ^a   Chongkolwatana, Viroje ^a   Issaragrisil, Surapol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Hematopoietic stem cell transplantation; HSCT; Killer cell immunoglobulin like receptors; KIR; Thai

Indexed keywords

CYCLOSPORIN A; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; DONOR; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR GENE; LEUKEMIA; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SIBLING; THAILAND; TREATMENT OUTCOME;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; RECEPTORS, KIR; SIBLINGS; SURVIVAL RATE; THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84869195931     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Middleton D, Curran M, Maxwell L. Natural killer cells and their receptors. Transpl Immunol 2002; 10: 147-64.
2. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 2007; 7: 329-39.
3. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005; 105: 4878-84.
4. Cook MA, Milligan DW, Fegan CD, Darbyshire PJ, Mahendra P, Craddock CF, et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521-6.
5. Bjorklund AT, Schaffer M, Fauriat C, Ringden O, Remberger M, Hammarstedt C, et al. NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation. Blood 2010; 115: 2686-94.
6. Gagne K, Brizard G, Gueglio B, Milpied N, Herry P, Bonneville F, et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63: 271-80.
7. Verheyden S, Schots R, Duquet W, Demanet C. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 2005; 19: 1446-51.
8. De Santis D, Bishara A, Witt CS, Nagler A, Brautbar C, Slavin S, et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulinlike receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 2005; 65: 519-28.
9. van der MA, Schaap NP, Schattenberg AV, van Cranenbroek B, Tijssen HJ, Joosten I. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients. Mol Immunol 2008; 45: 3631-8.
10. Schellekens J, Rozemuller EH, Petersen EJ, van den Tweel JG, Verdonck LF, Tilanus MG. Activating KIRs exert a crucial role on relapse and overall survival after HLA-identical sibling transplantation. Mol Immunol 2008; 45: 2255-61.
11. Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, et al. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood 2010; 115: 3162-5.
12. Mendez A, Granda H, Meenagh A, Contreras S, Zavaleta R, Mendoza MF, et al. Study of KIR genes in tuberculosis patients. Tissue Antigens 2006; 68: 386-9.
13. Norman PJ, Carrington CV, Byng M, Maxwell LD, Curran MD, Stephens HA, et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes Immun 2002; 3: 86-95.
14. Kulkarni S, Martin MP, Carrington M. KIR genotyping by multiplex PCR-SSP. Methods Mol Biol 2010; 612: 365-75.
15. th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA. Tissue Antigens 2010; 76: 9-17.
16. Tammakorn C, Mongkolsuk T, Thammanichanond D, Pakakasama S, Kitpoka P. Distribution of killer cell immunoglobulin-like receptor genes in Thai blood donors. J Med Assoc Thai 2011; 94: 738-42.
17. Lowe EJ, Turner V, Handgretinger R, Horwitz EM, Benaim E, Hale GA, et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. Br J Haematol 2003; 123: 323-6.
18. Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 2005; 106: 4370-6.
19. Dou LP, Zheng DH, Wang C, Liu JH, Sun JF, Jin HJ, et al. The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people. Int J Hematol 2008; 87: 422-33.